TrialDiabetes care2011

Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes.

Mathijs C Bunck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.